Chonluten

Overview

A short synthetic peptide bioregulator (Glu-Asp-Gly) from the Khavinson family, marketed for bronchial/lung epithelium support. Evidence is largely Russian-language and preclinical.

Mechanism of Action

Proposed tissue-specific peptide-bioregulator activity in respiratory epithelium; not established by independent research.

Research Summary

Primarily Russian institutional studies; no large independent controlled human trials.

Vendors selling Chonluten

Scored vendors carrying Chonluten, ranked by trust grade. Grades are computed from indexed Certificates of Analysis. Full $/mg pricing is on the comparison page.

Reported Side Effects

• Not well characterized

Compare Chonluten with Others

Frequently asked questions

Has Chonluten been independently lab-tested?

Disclosed Labs has collected 5 Certificates of Analysis (COA) for Chonluten from 3 independent testing labs. 3 vendors have submitted material for testing. Products average 99.4% tested purity across the corpus. Full testing data is available at https://www.disclosedlabs.com/peptides/chonluten/testing.

What is the average purity of Chonluten on the market?

Based on 5 COAs analyzed by Disclosed Labs, Chonluten products average 99.4% (±0.4%) tested purity. Individual vendor results vary; see per-vendor COA data at https://www.disclosedlabs.com/peptides/chonluten/coas.

Where can researchers source Chonluten?

1 vendor with Disclosed Labs trust grades currently list Chonluten, including BioLongevity Labs. Compare live prices and lab-verified COAs at https://www.disclosedlabs.com/prices/chonluten.

How does Chonluten work?

Proposed tissue-specific peptide-bioregulator activity in respiratory epithelium; not established by independent research.

What does the research say about Chonluten?

Primarily Russian institutional studies; no large independent controlled human trials.